Infinity Pharma adds another bull at JPMorgan on potential of cancer therapy
Infinity Pharmaceuticals (INFI) has climbed ~17.9% in the pre-market after JP Morgan upgraded the stock to overweight from neutral,…
Infinity Pharmaceuticals (INFI) has climbed ~17.9% in the pre-market after JP Morgan upgraded the stock to overweight from neutral,…
DALLAS–(BUSINESS WIRE)–RumbleOn Reports Second Quarter 2021 Earnings. Delivers 100% Revenue and 131% Gross Profit Growth, provides…
LONDON & NEW YORK–(BUSINESS WIRE)–AJAX I (“AJAX”) (NYSE: AJAX), a publicly-traded special purpose acquisition company (“SPAC”),…
Insider buying decreased last week. Selling also decreased significantly. Click here to read about the notable buys and sells…
The manufactured housing industry has entered a period of sustainable growth. I view the company as a solid long-term holding…
Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health…
Proceeds will fund continued development of IMVT-1401 in multiple indications NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — Immunovant,…
JAWS Hurricane Acquisition Corporation (Nasdaq: HCNEU) (the “Company”) announced that, commencing August 2, 2021, holders of…
MINNEAPOLIS, MN / ACCESSWIRE /August 2, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an…
U.S. stock futures gained ground Monday, the first trading day of August, after the S&P 500 logged its sixth straight monthly…